Related references
Note: Only part of the references are listed.Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Dalil Hannani et al.
CANCER JOURNAL (2011)
Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer
Koji Yasuda et al.
CANCER SCIENCE (2011)
Radiation-Induced Bystander Effects: What Are They, and How Relevant Are They to Human Radiation Exposures?
Benjamin J. Blyth et al.
RADIATION RESEARCH (2011)
Desirable cell death during anticancer chemotherapy
Clara Locher et al.
CLEARANCE OF DYING CELLS IN HEALTHY AND DISEASED IMMUNE SYSTEMS (2010)
Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine
Benedetto Farsaci et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Standard treatments induce antigen-specific immune responses in prostate cancer
Nancy J. Nesslinger et al.
CLINICAL CANCER RESEARCH (2007)
Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis
A Gelbard et al.
CLINICAL CANCER RESEARCH (2006)
The controversial abscopal effect
JM Kaminski et al.
CANCER TREATMENT REVIEWS (2005)
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer
JL Gulley et al.
CLINICAL CANCER RESEARCH (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing
M Chakraborty et al.
CANCER RESEARCH (2004)
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes
CT Garnett et al.
CANCER RESEARCH (2004)
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy
M Chakraborty et al.
JOURNAL OF IMMUNOLOGY (2003)
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
AK Nowak et al.
JOURNAL OF IMMUNOLOGY (2003)
Immune modulation by ionizing radiation and its implications for cancer immunotherapy
EJ Friedman
CURRENT PHARMACEUTICAL DESIGN (2002)
Characterization of CD8(+) cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant
MH Ryan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
RM Siegel et al.
NATURE IMMUNOLOGY (2000)
Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
JL Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules
JW Hodge et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors
JC Yang et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Share Paper
